CBiolab

C-Biolab is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and diagnostics. The company leverages its proprietary platform for the efficient isolation and engineering of exosomes to deliver therapeutic payloads, such as proteins or nucleic acids, to specific target cells. Their primary research focus includes oncology, inflammatory disorders, and sepsis. C-Biolab aims to overcome the limitations of traditional drug delivery systems by utilizing the natural biocompatibility and targeting capabilities of exosomes. The company's core technologies, Exo-Pure and Exo-Target, facilitate high-purity exosome extraction and precise cargo loading.